Skip to main content

Advertisement

Table 2 Multiplicity of infection and proportion of polyclonal infections according to previous IPTi with SP

From: Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants

Stratum No. IPTI : placebo mean MOI (median, range) P Proportion of polyclonal infections (%) P
   Previous IPTi Previous Placebo   Previous IPTi Previous Placebo  
All 191 : 198 2.25 (2, 1-5) 2.33 (2, 1-6) 0.55 69.6 69.7 0.99
All microscopically positive 135 : 142 2.42 (2, 1-5) 2.38 (2, 1-6) 0.78 74.8 72.5 0.67
Afigya Sekyere 85 : 88 2.29 (2, 1-5) 2.31 (2, 1-6) 0.92 69.4 71.6 0.75
Tamale, all 106 : 110 2.22 (2, 1-5) 2.35 (2, 1-5) 0.49 69.8 68.2 0.80
Tamale, microscopically positive 50 : 54 2.64 (2.5, 1-5) 2.50 (2, 1-5) 0.59 84.0 74.1 0.22
Tamale, submicroscopic 56 : 56 1.84 (2, 1-5) 2.20 (2, 1-5) 0.17 57.1 62.5 0.56
  1. P, comparisons by Mann-Whitney U test or χ2 test